LGALS3 and chronic kidney disease: In individuals with chronic kidney disease (CKD), galectin-3 levels were correlated with echocardiography parameters indicative of diastolic dysfunction, suggesting its utility as a biomarker for cardiac fibrosis and dysfunction in this population [54].